Portfolio
2
companies
Cambridge Photon Technology
Cambridge Photon Technology develops drop-in materials to increase solar panel power output.
DefiniGEN
DefiniGEN creates human cell models to support drug discovery and preclinical research.
The funding comprises private equity and a state grant to expand research and development operations.
"Cambridge Photon Technology exemplifies the kind of transformative innovation needed to accelerate the global transition to sustainable energy and address climate challenges."
The follow-on investment will fund the commercial launch of new pancreatic and lung stem cell products.
"In a short space of time, DefiniGEN has undergone rapid development, securing growing sales with global pharma companies. We are delighted to have raised the funds that will allow us to deliver new market-leading products to our customers and assist them in developing therapies for the global healthcare challenges we face today such as diabetes and liver disease."
